Koers Aradigm Corporation Nasdaq
Aandelen
US0385054004
Biotechnologie & Medisch Onderzoek
Omzet 2016 | 195K 182K | Omzet 2017 | 14,46 mln. 13,53 mln. | Marktkapitalisatie | 97,3 mln. 91 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2016 | -32 mln. -29,93 mln. | Nettowinst (verlies) 2017 | -10 mln. -9,35 mln. | EV/omzet 2016 | 73,3 x |
Nettoliquiditeiten 2016 | 9,37 mln. 8,77 mln. | Nettoschuld 2017 | 7,91 mln. 7,4 mln. | EV/omzet 2017 | 7,27 x |
K/w-verhouding 2016 |
-0,72
x | K/w-verhouding 2017 |
-9,3
x | Werknemers | - |
Dividendrendement 2016 * |
-
| Dividendrendement 2017 |
-
| Vrij verhandelbaar | 60,28% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,51% | 42,75 mld. | |
+8,57% | 41,34 mld. | |
+49,22% | 41,61 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |